Thrasos Therapeutics

Thrasos is a private, clinical‑stage biotherapeutics company focused on delivering new solutions to individuals affected by kidney disease. The company has two major programs; its lead program targets acute kidney injury (AKI) while the second program addresses diabetic nephropathy, a leading cause of chronic kidney disease (CKD).